Montel Williams Debuts Line of Medical Cannabis Products
San Francisco, CA - April 20, 2017 (Investorideas.com Newswire) On Tuesday April 18, 2017, Lenitiv Scientific LLC debuts its line of high-quality medical cannabis products for patients, under the brand name LenitivLabs, in dispensaries across California. Alongside the debut, media personality Montel Williams, founder of Lenitiv Scientific, will host the following launch events at Bay Area dispensaries:
- April 18, 7pm to 9pm, at Caliva (1695 S 7th St, San Jose, CA 95112)
- April 19, 7pm to 9pm, at Purple Lotus Patient Center (752 Commercial St #20, San Jose, CA 95112)
- April 21, 7pm to 9pm, at Harvest on Geary (4811 Geary Blvd, San Francisco, CA 94118)
LenitivLabs' line of proprietary products utilize the latest cannabis manufacturing technologies and research to deliver the highest quality and consistency to patients. The line includes cannabis oils that patients can conveniently load into vaporizers as well as a cannabis infused drink. Patients will feel safe knowing there are no harmful additives and the products are clearly labeled and packaged in consistent, standardized doses.
"I'm thrilled to be debuting LenitivLabs," says founder Montel Williams. "My mission—and the mission of our entire Lenitiv team—is to ensure that patients like myself have access to the highest-quality medicine available."
Williams—an award-winning media personality, decorated former Naval officer, entrepreneur, and wellness advocate—was diagnosed with Multiple Sclerosis (MS) in 1999 and has used cannabis products as a medication to manage the disease's symptoms.
"Medical cannabis has allowed me to live a productive, fruitful life despite having multiple sclerosis," says Williams. "Many thousands of others across this country have experienced the same thing, which is what drove me to launch Lenitiv Scientific."
Williams is one of the nation's highest-profile advocates for cannabis law reform and has championed the cause for the past seventeen years. He has worked to pass medical cannabis legislation in states such as Pennsylvania, New York, Ohio, New Jersey, and Connecticut and continues to advocate for reform at the federal level and in states where medical cannabis laws are not currently in effect. An outspoken advocate for America's servicemen and women, Williams has led the push for military veterans to legally access medical cannabis without the threat of losing benefits.
Beginning in April, LenitivLabs' product line will be available for patients with a doctor's recommendation at dispensaries throughout northern and southern California (for a full list of dispensaries that carry LenitivLabs, please visit the LenitivLabs website) with plans to expand to other states that allow for the sale of medical cannabis.
Note: Lenitiv Labs, LLC operates in California as a non-profit mutual benefit corporation. All products are manufactured in a licensed facility in strict compliance with local and state laws. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.
About Lenitiv Scientific
Lenitiv Scientific develops innovative, high quality medical cannabis products for patients. The company works closely with regulators and provides education for the broader community on topics such as proper dosage and methods of delivery. Lenitiv Scientific was founded by Montel Williams and former pharmaceutical executive David Racz, who serves as CEO. The company's world class advisory board includes Former Director, Central Intelligence, Ambassador R. James Woolsey; Retired Vice Admiral Edward M. Straw; former Congressman Wilbert Tauzin, former owner of General Drug, Basil Falcone; Lindy Snider; and Nancye Miller-Woolsey.
Related Links: http://lenitivlabs.com
Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Global Cannabis Investing - features Investor Ideas Cannabis news
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.